The world’s Largest Sharp Brain Virtual Experts Marketplace Just a click Away
Levels Tought:
Elementary,Middle School,High School,College,University,PHD
| Teaching Since: | Jul 2017 |
| Last Sign in: | 398 Weeks Ago, 3 Days Ago |
| Questions Answered: | 5023 |
| Tutorials Posted: | 5024 |
A pharmaceutical company develops a new drug that helps obese patients who are not currently diabetic avoid contraction of diabetes. The conduct conducts a trial splitting a sample of 135 patients into two groups, a drug group and a placebo group. They then monitored the patients for 5 years and noted how many patients in each group contracted diabetes. The company wants to conduct a Chi-Squared test for Independence to assess whether their new drug has any effect on the contraction of diabetes amongst obese patients. Use this data to answer questions 1-3. Number of Patients Drug Placebo Contracted diabetes 51 18 Did not contract diabetes 39 27 2 1. Identify the correct critical value, def . (10%) 2 2. Calculate the test statistic, X59“ . (10%) 3. The company statistician tells you that the p-value of the test is 0.0678. Compare the test statistic to the critical value. Compare the p-value to alpha. Is there statistically significant evidence to suggest that the drug is effective in preventing the contraction of diabetes? Explain why or why not. (20%)Â
This text was automatically generated from the attachment. Please refer to the attachment to view this question.Â
This question was created from HSCI 2117 Problem Set 6 Updated.docx https://www.coursehero.com/file/24268380/HSCI-2117-Problem-Set-6-Updateddocx/?focusQaId=10814016
Hel-----------lo -----------Sir-----------/Ma-----------dam----------- Â----------- -----------Tha-----------nk -----------you----------- fo-----------r y-----------our----------- in-----------ter-----------est----------- an-----------d b-----------uyi-----------ng -----------my -----------pos-----------ted----------- so-----------lut-----------ion-----------. P-----------lea-----------se -----------pin-----------g m-----------e o-----------n c-----------hat----------- I -----------am -----------onl-----------ine----------- or----------- in-----------box----------- me----------- a -----------mes-----------sag-----------e I----------- wi-----------ll -----------be -----------qui-----------ckl-----------y